This site is intended for health professionals only!

Published on 6 July 2007

Share this story:
Twitter
LinkedIn
RELATED ARTICLES
Strategic review of the future pharmacist workforce
Repatha® (evolocumab) selected as a Rapid Uptake Product
ACE-inhibitors or angiotensin-receptor blockers and increased risk of death in COVID-19?
Pfizer moves forward with MRSA drug
No evidence authorised generics delay copycats, says US study

Alert on Rocephin neonate risk

teaser

US regulators have warned of the potential risk to newborn babies associated with Roche



Most read

1
Feedback: Automation systems in your hospital
2
Helapet introduce new, improved 20mm Vented Vial Adapter
3
User-friendly osteoporosis therapy launched
4
Merck agrees huge Vioxx settlement
5
Janssen-Cilag’s Stelara approved by NICE



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:
Twitter
LinkedIn
RELATED ARTICLES
Pradaxa® impacts AF stroke prevention
Hospital bugs “linked to cosmetics”
UCB to become a strategic investor in WILEX
Containing hazardous drugs
Cabazitaxel in castration-resistant prostate cancer